Literature DB >> 360836

Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome.

J R Gill, F C Bartter.   

Abstract

Maximal free-water clearance was measured in five patients with Bartter's syndrome and in five patients with the hypokalemic alkalosis of persistent psychogenic vomiting. Hypokalemic alkalosis, hyperreninemia, hyperaldosteronism and excessive renal production of prostaglandin E2 were present in the patients with both disorders. Maximal free water clearance was abnormally low, in association with a high clearance of chloride, in all the patients with Bartter's syndrome; it was normal in all the patients with psychogenic vomiting. In the patients with Bartter's syndrome, apparent distal delivery of proximal tubular fluid was inversely related to glomerular filtration rate and was excessive only in those patients with a low glomerular filtration rate. Patients with psychogenic vomiting showed mean distal fractional chloride reabsorption of 0.92 +/- 0.04 (standard error [SE]). In the patients with Bartter's syndrome, distal fractional reabsorption of chloride was 0.49 +/- 0.08 and was the same (0.46 +/- 0.06) during inhibition of prostaglandin synthesis with indomethacin therapy. Thus, a prostaglandin-independent defect in chloride reabsorption in the loop of Henle is the most proximal cause for the abnormalities in Bartter's syndrome thus far identified.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360836     DOI: 10.1016/0002-9343(78)90794-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

Review 1.  The pathophysiological and molecular basis of Bartter's and Gitelman's syndromes.

Authors:  S Bhandari
Journal:  Postgrad Med J       Date:  1999-07       Impact factor: 2.401

Review 2.  Understanding Bartter syndrome and Gitelman syndrome.

Authors:  Oliver T Fremont; James C M Chan
Journal:  World J Pediatr       Date:  2012-01-27       Impact factor: 2.764

Review 3.  Small-intestinal abnormalities in cystic fibrosis patients.

Authors:  E Eggermont; K De Boeck
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

Review 4.  ClC transporters: discoveries and challenges in defining the mechanisms underlying function and regulation of ClC-5.

Authors:  Leigh Wellhauser; Christina D'Antonio; Christine E Bear
Journal:  Pflugers Arch       Date:  2010-01-05       Impact factor: 3.657

Review 5.  Threading through the mizmaze of Bartter syndrome.

Authors:  Willem Proesmans
Journal:  Pediatr Nephrol       Date:  2006-05-16       Impact factor: 3.714

6.  Myotonia as a side effect of diuretic action.

Authors:  A H Bretag; S R Dawe; D I Kerr; A G Moskwa
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Formation and action of prostaglandins in the kidney.

Authors:  P C Weber; B Scherer; W Siess; E Held; J Schnermann
Journal:  Klin Wochenschr       Date:  1979-10-01

8.  Ammonium urate nephrolithiasis in a variant of Bartter's syndrome with intact renal tubular function.

Authors:  G Yasuda; R Zierer; A Maio; H Shioniri; M Ishii; S Umemura
Journal:  Clin Investig       Date:  1994-05

9.  Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice.

Authors:  Ming Lu; Tong Wang; Qingshang Yan; Xinbo Yang; Ke Dong; Mark A Knepper; WenHui Wang; Gerhard Giebisch; Gary E Shull; Steven C Hebert
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

10.  Angiotensin-converting enzyme inhibition as a therapeutic principle in Bartter's syndrome.

Authors:  P Jest; K E Pedersen; N A Klitgaard; N Thomsen; K Kjaer; E Simonsen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.